Vicarious Surgical Inc. RBOT

No annual revenue total was found in VICARIOUS SURGICAL INC.'s SEC filings.

Vicarious Surgical Inc. (RBOT) files with the SEC under industry code 3842, Orthopedic, Prosthetic & Surgical Appliances & Supplies. Free cash flow was -$45.2 million. As of Dec 31, 2025 it held $9.8 million in cash and investments and $7.3 million in total debt.

Revenue
—
Net income
$-50.18M
+20.6% vs prior year
Operating cash flow
$-45.08M
+9.8% vs prior year
Free cash flow
$-45.21M
+9.8% vs prior year
EPS
$-0.49
-1325.0% vs prior year
Dividend per share
None
Shares outstanding
—
Net cash
$2.53M
FY 2025
Operating margin
—

Company profile

Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842)
Listed as
RBOT (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Waltham, MA
SEC filer status
, Emerging growth company
SEC CIK
1812173
Former names
D8 Holdings Corp. (until Sep 20, 2021)

Other Orthopedic, Prosthetic & Surgical Appliances & Supplies companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
Operating income
-$50.0M
-$66.6M
-$80.7M
-$80.1M
-$38.2M
Net income
-$50.2M
-$63.2M
-$71.1M
$5.2M
-$35.2M
Diluted EPS
—
—
-$0.49
$0.04
-$0.36
Operating cash flow
-$45.1M
-$50.0M
-$62.3M
-$61.2M
-$33.3M
Free cash flow
-$45.2M
-$50.1M
-$64.0M
—
-$34.6M
Total assets
$19.6M
$67.7M
$119.9M
$140.3M
$181.7M
Total liabilities
$9.7M
$21.0M
$21.9M
$29.2M
$98.6M
Stockholders' equity
$9.8M
$46.7M
$98.0M
$111.0M
$83.1M
Cash and investments
$9.8M
$49.1M
$98.2M
$116.2M
$173.5M
Total debt
$7.3M
$13.8M
$16.8M
$15.7M
$675,000

Recent SEC filings

Recent SEC filings
Form Description Filed Period
8-K Current report
Material agreement, Acquisition or sale of assets, Officer or director change, Shareholder vote results, Other events
Jul 21, 2026 Jul 21, 2026
8-K Current report
Officer or director change
Jun 24, 2026 Jun 24, 2026
10-Q Quarterly report Apr 30, 2026 Mar 31, 2026
8-K Current report
Shareholder vote results
Apr 8, 2026 Apr 8, 2026
8-K Current report
Results of operations, Other events
Mar 9, 2026 Mar 9, 2026
10-K Annual report Mar 9, 2026 Dec 31, 2025

Source: SEC EDGAR filings. This is company-reported data, not investment advice.